Skip to main navigation Skip to search Skip to main content

Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics

  • Josephine Bourner
  • , Michel Vaillant
  • , Alex Paddy Abdel Salam
  • , Marie Jaspard
  • , Camille Fritzell
  • , Shevin Jacob
  • , Tom Fletcher
  • , Michael Ramharter
  • , Nnennaya Ajayi
  • , Sylvanus Okogbenin
  • , Cyril Erameh
  • , Donald Grant
  • , Robert Samuels
  • , Oladele Oluwafemi Ayodeji
  • , Armand Sprecher
  • , Bronner P. Gonçalves
  • , Tansy Edwards
  • , Piero Olliaro
  • University of Oxford
  • Luxembourg Institute of Health
  • Sorbonne Université
  • Route des Almadies
  • Institut national de la santé et de la recherche médicale
  • University of Hamburg
  • German Center for Infection Research, Giessen - Marburg - Langen Partner Site
  • Alex Ekwueme Federal University Teaching Hospital
  • Irrua Specialist Teaching Hospital
  • Kenema Government Hospital
  • Federal Medical Centre
  • Medecins Sans Frontieres
  • London School of Hygiene and Tropical Medicine

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Mathematics

Chemistry